NC ACO Public Reporting

ACO name and location:

Novant Health Accountable Care Organization I, LLC
200 Hawthorne Lane, P.O. Box 33549,
Charlotte, NC 28233

ACO primary contacts:

Robert Eberle, MD
336-277-2428
raeberle@novanthealth.org

Organizational information:

ACO participants:

Carolina Medicorp Enterprises, Inc.
Forsyth Medical Group, LLC
Forsyth Memorial Hospital, Inc.
Foundation Health Systems Corp
Northwest Family Physicians, P.A.
Novant Medical Group, Inc.
Piedmont Family Medicine, PA
Presbyterian Medical Care Corp
Rowan Diagnostic Clinic, PA
The Presbyterian Hospital

ACO participants in joint ventures between ACO professionals and hospitals: None

ACO governing body:

Name:	Member type:	Governing body role:	Voting capacity:	ACO participant (TIN) legal name
Stephen Wallenhaupt, MD	Medicare beneficiary representative	Serves on board of managers; chairperson	Voting member (1)	N/A
Robert Barnabei, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Novant Medical Group, Inc.
Carl Smart, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Novant Medical Group, Inc.
Betsy English, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Forsyth Memorial Hospital, Inc.
Jacques Laguerre, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Novant Medical Group, Inc.
Michael Hoben, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Carolina Medicorp Enterprises, Inc.
Jerome Williams, MD	ACO participant representative	Serves on board of managers	Voting member (1)	Novant Medical Group, Inc.
Shelbourn Stevens	Other representative	Serves on board of managers	Voting member (1)	N/A

Key ACO clinical and administrative leadership:

ACO Executive: Robert Eberle, MD
Medical director: Michael Hoben, MD
Compliance officer: Lee Decker
Quality Assurance/Improvement Officer: Robert Barnabei, MD

Associated committees and committee leadership:

Network development committee: Patrick Easterling, Chair
Quality committee: Robert Barnabei, MD, Chair
Finance committee: Geoff Gardner, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

ACO professionals in a group practice arrangement
Hospital employing ACO professionals

Amount of Shared Savings and Losses:

First Agreement Period

Performance Year 2017, $0

Shared savings distribution:

First Agreement Period

Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A

Quality Performance Results:

2017 Quality Performance Results:

ACO#	Measure Name	Rate	ACO Mean
ACO-1	CAHPS: Getting Timely Care, Appointments, and Information	83.69	80.60
ACO-2	CAHPS: How Well Your Providers Communicate	94.01	93.13
ACO-3	CAHPS: Patients’ Rating of Provider	93.86	92.31
ACO-4	CAHPS: Access to Specialists	86.85	83.32
ACO-5	CAHPS: Health Promotion and Education	66.24	62.30
ACO-6	CAHPS: Shared Decision Making	76.84	75.85
ACO-7	CAHPS: Health Status/Functional Status	75.74	73.05
ACO-34	CAHPS: Stewardship of Patient Resources	30.69	25.68
ACO-8	Risk Standardized, All Condition Readmission	14.53	15.01
ACO-35	Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)	19.27	18.46
ACO-37	All-Cause Unplanned Admissions for Patients with Heart Failure	73.75	79.16
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	54.49	61.74
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	1.73	1.93
ACO-11	Use of Certified EHR Technology	100.00	98.48
ACO-12	Medication Reconciliation	95.59	75.32
ACO-13	Falls: Screening for Future Fall Risk	91.93	74.38
ACO-44	Imaging Studies for Low Back Pain	59.28	67.32
ACO-14	Preventive Care and Screening: Influenza Immunization	71.21	72.52
ACO-15	Pneumonia Vaccination Status for Older Adults	81.10	72.92
ACO-16	Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up	40.32	70.69
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	98.41	90.48
ACO-18	Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan	74.62	61.98
ACO-19	Colorectal Cancer Screening	69.44	64.58
ACO-20	Breast Cancer Screening	74.91	70.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	84.23	79.89
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	11.80	16.74
ACO-41	Diabetes: Eye Exam	49.84	50.37
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	74.66	71.47
ACO-30	Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic	89.67	86.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size and the ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes quality measure is not included in public reporting due to a non-material technical error.

For 2017 Quality Performance Results please click here.

Note: In the Quality Performance Results file(s) above, search for “Novant Health Accountable Care Organization I, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A37836 in the public use files on data.cms.gov.

Payment Rule Waivers:

No, our ACO does not use the SNF 3-Day Rule Waiver.